Multiple Sclerosis, Disease-Modifying Therapies, and Infections
BACKGROUND AND OBJECTIVESThe use of highly effective multiple sclerosis (MS) disease-modifying therapies (DMTs) is rapidly increasing. Yet, little is known about their real-world risks of infections. The goals of this study were to assess the comparative risk of outpatient and serious infections acr...
Gespeichert in:
Veröffentlicht in: | Neurology : neuroimmunology & neuroinflammation 2023-11, Vol.10 (6) |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!